Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Risk factors for graft failure in kidney transplantation

Section Editor
Daniel C Brennan, MD, FACP
Deputy Editor
Albert Q Lam, MD


Despite significant improvements in one-year kidney allograft survival [1], the rate of chronic graft loss after the first year remains substantial and may not have improved over the last decade. As an example, a 2004 study that analyzed first renal transplants performed between 1995 and 2000 found that, despite a reduction in acute rejection rates, there was no improvement over the last 10 years in long-term allograft survival [2]. Despite this, the rate of decline in kidney allograft function appears to have slowed [3], suggesting that improved results relating to long-term allograft survival are possible.

Allograft survival rates also vary among different ethnic groups [4]. This may be explained in part by the presence of a disproportionately higher number of risk factors among certain patient populations and differences in access to health care [5-10].

The following discussion will review the determinants of short-term and long-term graft survival. However, this distinction is to some degree arbitrary since most factors can affect both. As an example, any short-term event that predisposes to episodes of acute rejection will then lead to a greater likelihood of chronic graft loss. In addition, many of these factors influence each other, such as human leukocyte antigen (HLA) mismatching, which may increase the risk of acute renal rejection and subsequent premature allograft failure. A discussion of patient survival after renal transplantation is presented separately. (See "Patient survival after renal transplantation".)


The risk of graft loss has traditionally been divided into an early, high-risk period and a later period of constant low risk [11,12]. A major improvement in renal allograft survival in the past 20 years has been the relative elimination of the early risk period.

A number of factors have been shown to influence short-term graft survival. These include delayed allograft function, human leukocyte antigen (HLA) antibodies, type of donor kidney, donor illness, medical center factors, and other factors.

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:

Subscribers log in here

Literature review current through: Nov 2017. | This topic last updated: Oct 27, 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
  1. Hariharan S, Johnson CP, Bresnahan BA, et al. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000; 342:605.
  2. Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 2004; 4:378.
  3. Kasiske BL, Gaston RS, Gourishankar S, et al. Long-term deterioration of kidney allograft function. Am J Transplant 2005; 5:1405.
  4. Higgins RS, Fishman JA. Disparities in solid organ transplantation for ethnic minorities: facts and solutions. Am J Transplant 2006; 6:2556.
  5. Cecka JM. The UNOS Scientific Renal Transplant Registry 1996. In: Clinical Transplants, Terasaki PI (Ed), UCLA Tissue Typing Laboratory, Los Angeles 1997. p.1.
  6. Isaacs RB, Nock SL, Spencer CE, et al. Racial disparities in renal transplant outcomes. Am J Kidney Dis 1999; 34:706.
  7. Kasiske BL, Chakkera H. Successful renal transplantation in American Indians. Transplantation 1998; 66:209.
  8. Chakkera HA, O'Hare AM, Johansen KL, et al. Influence of race on kidney transplant outcomes within and outside the Department of Veterans Affairs. J Am Soc Nephrol 2005; 16:269.
  9. Pallet N, Thervet E, Alberti C, et al. Kidney transplant in black recipients: are African Europeans different from African Americans? Am J Transplant 2005; 5:2682.
  10. Goldfarb-Rumyantzev AS, Koford JK, Baird BC, et al. Role of socioeconomic status in kidney transplant outcome. Clin J Am Soc Nephrol 2006; 1:313.
  11. Terasalo PI, Cecka JM, Gjertson DW, et al. Risk rate and long-term kidney transplant survival. In: Clinical Transplants 1996, Terasaki PI (Ed), UCLA Tissue Typing Laboratory, Los Angeles 1997. p.443.
  12. Prommool S, Jhangri GS, Cockfield SM, Halloran PF. Time dependency of factors affecting renal allograft survival. J Am Soc Nephrol 2000; 11:565.
  13. Quiroga I, McShane P, Koo DD, et al. Major effects of delayed graft function and cold ischaemia time on renal allograft survival. Nephrol Dial Transplant 2006; 21:1689.
  14. Terasaki PI, Ozawa M. Predicting kidney graft failure by HLA antibodies: a prospective trial. Am J Transplant 2004; 4:438.
  15. Port FK, Dykstra DM, Merion RM, Wolfe RA. Trends and results for organ donation and transplantation in the United States, 2004. Am J Transplant 2005; 5:843.
  16. US Transplant http://www.ustransplant.org (Accessed on February 10, 2010).
  17. Rigden S, Mehls O, Gellert R. Factors influencing second renal allograft survival. Scientific Advisory Board of the ERA-EDTA Registry. European Renal Association-European Dialysis and Transplant Association. Nephrol Dial Transplant 1999; 14:566.
  18. Organ Procurement and Transplantation Network http://www.optn.org (Accessed on February 11, 2010).
  19. Sellers MT, Velidedeoglu E, Bloom RD, et al. Expanded-criteria donor kidneys: a single-center clinical and short-term financial analysis--cause for concern in retransplantation. Transplantation 2004; 78:1670.
  20. Woo YM, Gill JS, Johnson N, et al. The advanced age deceased kidney donor: current outcomes and future opportunities. Kidney Int 2005; 67:2407.
  21. http://optn.transplant.hrsa.gov/SharedContentDocuments/KidneyConceptDocument.PDF (Accessed on February 25, 2013).
  22. Rao PS, Schaubel DE, Guidinger MK, et al. A comprehensive risk quantification score for deceased donor kidneys: the kidney donor risk index. Transplantation 2009; 88:231.
  23. Kim SJ, Schaubel DE, Jeffery JR, Fenton SS. Centre-specific variation in renal transplant outcomes in Canada. Nephrol Dial Transplant 2004; 19:1856.
  24. Evans RW, Manninen DL, Dong F. The center effect in kidney transplantation. Transplant Proc 1991; 23:1315.
  25. Taylor RM, Ting A, Briggs JD. Renal transplantation in the United Kingdom and Ireland--the centre effect. Lancet 1985; 1:798.
  26. Cho YW, Cecka JM. Organ procurement organization and transplant center effects on cadaveric renal transplant outcomes. In: Clinical Transplants 1996, Terasaki PI (Ed), UCLA Tissue Typing Laboratory, Los Angeles 1997. p.427.
  27. Summers DM, Johnson RJ, Hudson A, et al. Effect of donor age and cold storage time on outcome in recipients of kidneys donated after circulatory death in the UK: a cohort study. Lancet 2013; 381:727.
  28. Watson CJ, Johnson RJ, Birch R, et al. A simplified donor risk index for predicting outcome after deceased donor kidney transplantation. Transplantation 2012; 93:314.
  29. Ojo AO, Leichtman AB, Punch JD, et al. Impact of pre-existing donor hypertension and diabetes mellitus on cadaveric renal transplant outcomes. Am J Kidney Dis 2000; 36:153.
  30. Fellström B, Holdaas H, Jardine AG, et al. Risk factors for reaching renal endpoints in the assessment of Lescol in renal transplantation (ALERT) trial. Transplantation 2005; 79:205.
  31. He X, Johnston A. Risk factors for allograft failure in United kingdom renal transplant recipients treated with cyclosporine A. Transplantation 2005; 79:953.
  32. Hariharan S, McBride MA, Cherikh WS, et al. Post-transplant renal function in the first year predicts long-term kidney transplant survival. Kidney Int 2002; 62:311.
  33. Salvadori M, Rosati A, Bock A, et al. Estimated one-year glomerular filtration rate is the best predictor of long-term graft function following renal transplant. Transplantation 2006; 81:202.
  34. Tullius SG, Tilney NL. Both alloantigen-dependent and -independent factors influence chronic allograft rejection. Transplantation 1995; 59:313.
  35. Matas AJ, Gillingham KJ, Humar A, et al. Immunologic and nonimmunologic factors: different risks for cadaver and living donor transplantation. Transplantation 2000; 69:54.
  36. Delmonico FL. Analyzing risk factors of renal transplant outcome. Transplantation 2000; 69:1.
  37. Basadonna GP, Matas AJ, Gillingham KJ, et al. Early versus late acute renal allograft rejection: impact on chronic rejection. Transplantation 1993; 55:993.
  38. Almond PS, Matas A, Gillingham K, et al. Risk factors for chronic rejection in renal allograft recipients. Transplantation 1993; 55:752.
  39. Pallardó Mateu LM, Sancho Calabuig A, Capdevila Plaza L, Franco Esteve A. Acute rejection and late renal transplant failure: risk factors and prognosis. Nephrol Dial Transplant 2004; 19 Suppl 3:iii38.
  40. Meier-Kriesche HU, Ojo AO, Hanson JA, et al. Increased impact of acute rejection on chronic allograft failure in recent era. Transplantation 2000; 70:1098.
  41. Cole EH, Johnston O, Rose CL, Gill JS. Impact of acute rejection and new-onset diabetes on long-term transplant graft and patient survival. Clin J Am Soc Nephrol 2008; 3:814.
  42. Opelz G. The benefit of exchanging donor kidneys among transplant centers. N Engl J Med 1988; 318:1289.
  43. Giblin L, O'Kelly P, Little D, et al. A comparison of long-term graft survival rates between the first and second donor kidney transplanted--the effect of a longer cold ischaemic time for the second kidney. Am J Transplant 2005; 5:1071.
  44. Cecka JM. Living donor transplants. In: Clinical Transplants 1995, Terasaki PI (Ed), UCLA Tissue Typing Laboratory, Los Angeles 1996. p.363.
  45. Terasaki PI, Cecka JM, Gjertson DW, Takemoto S. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 1995; 333:333.
  46. Humar A, Durand B, Gillingham K, et al. Living unrelated donors in kidney transplants: better long-term results than with non-HLA-identical living related donors? Transplantation 2000; 69:1942.
  47. Cecka JM, Cho L. Sensitization. In: Clinical Transplants 1988, Terasaki PI (Ed), UCLA Tissue Typing Laboratory, Los Angeles 1989. p.365.
  48. Redfield RR, Scalea JR, Zens TJ, et al. The mode of sensitization and its influence on allograft outcomes in highly sensitized kidney transplant recipients. Nephrol Dial Transplant 2016; 31:1746.
  49. Lefaucheur C, Suberbielle-Boissel C, Hill GS, et al. Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation. Am J Transplant 2008; 8:324.
  50. Loupy A, Lefaucheur C, Vernerey D, et al. Complement-binding anti-HLA antibodies and kidney-allograft survival. N Engl J Med 2013; 369:1215.
  51. Opelz G, Collaborative Transplant Study. Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies. Lancet 2005; 365:1570.
  52. Terasaki PI, Ozawa M. Predictive value of HLA antibodies and serum creatinine in chronic rejection: results of a 2-year prospective trial. Transplantation 2005; 80:1194.
  53. Bryan CF, Mitchell SI, Lin HM, et al. Influence of the Rh (D) blood group system on graft survival in renal transplantation. Transplantation 1998; 65:588.
  54. Escofet X, Osman H, Griffiths DF, et al. The presence of glomerular sclerosis at time zero has a significant impact on function after cadaveric renal transplantation. Transplantation 2003; 75:344.
  55. Tullius SG, Volk HD, Neuhaus P. Transplantation of organs from marginal donors. Transplantation 2001; 72:1341.
  56. Ponticelli C, Villa M, Cesana B, et al. Risk factors for late kidney allograft failure. Kidney Int 2002; 62:1848.
  57. Lu CY, Penfield JG, Kielar ML, et al. Hypothesis: is renal allograft rejection initiated by the response to injury sustained during the transplant process? Kidney Int 1999; 55:2157.
  58. Pratschke J, Vok HD. Brain death-associated ischemia and reperfusion injury. Curr Opin Organ Transplant 2004; 9:153.
  59. Novitzky D, Rose AG, Cooper DK. Injury of myocardial conduction tissue and coronary artery smooth muscle following brain death in the baboon. Transplantation 1988; 45:964.
  60. Stokes KY, Abdih HK, Kelly CJ, et al. Thermotolerance attenuates ischemia-reperfusion induced renal injury and increased expression of ICAM-1. Transplantation 1996; 62:1143.
  61. van der Hoeven JA, Molema G, Ter Horst GJ, et al. Relationship between duration of brain death and hemodynamic (in)stability on progressive dysfunction and increased immunologic activation of donor kidneys. Kidney Int 2003; 64:1874.
  62. Labarrere CA, Pitts D, Nelson DR, Faulk WP. Vascular tissue plasminogen activator and the development of coronary artery disease in heart-transplant recipients. N Engl J Med 1995; 333:1111.
  63. Debout A, Foucher Y, Trébern-Launay K, et al. Each additional hour of cold ischemia time significantly increases the risk of graft failure and mortality following renal transplantation. Kidney Int 2015; 87:343.
  64. Lim EC, Terasaki PI. Early graft funciton. In: Clinical Transplants 1990, Terasaki PI (Ed), UCLA Tissue Typing Laboratory, Los Angeles 1991.
  65. Opelz G, Döhler B. Multicenter analysis of kidney preservation. Transplantation 2007; 83:247.
  66. Troppmann C, Gillingham KJ, Gruessner RW, et al. Delayed graft function in the absence of rejection has no long-term impact. A study of cadaver kidney recipients with good graft function at 1 year after transplantation. Transplantation 1996; 61:1331.
  67. Morris PJ, Johnson RJ, Fuggle SV, et al. Analysis of factors that affect outcome of primary cadaveric renal transplantation in the UK. HLA Task Force of the Kidney Advisory Group of the United Kingdom Transplant Support Service Authority (UKTSSA). Lancet 1999; 354:1147.
  68. Wigmore SJ, Seeney FM, Pleass HC, et al. Kidney damage during organ retrieval: data from UK National Transplant Database. Kidney Advisory Group. Lancet 1999; 354:1143.
  69. Giral-Classe M, Hourmant M, Cantarovich D, et al. Delayed graft function of more than six days strongly decreases long-term survival of transplanted kidneys. Kidney Int 1998; 54:972.
  70. Peters TG, Shaver TR, Ames JE 4th, et al. Cold ischemia and outcome in 17,937 cadaveric kidney transplants. Transplantation 1995; 59:191.
  71. Schnuelle P, Lorenz D, Mueller A, et al. Donor catecholamine use reduces acute allograft rejection and improves graft survival after cadaveric renal transplantation. Kidney Int 1999; 56:738.
  72. Bryan CF, Luger AM, Martinez J, et al. Cold ischemia time: an independent predictor of increased HLA class I antibody production after rejection of a primary cadaveric renal allograft. Transplantation 2001; 71:875.
  73. Chandraker A, Takada M, Nadeau KC, et al. CD28-b7 blockade in organ dysfunction secondary to cold ischemia/reperfusion injury. Kidney Int 1997; 52:1678.
  74. Waldman WJ, Knight DA. Cytokine-mediated induction of endothelial adhesion molecule and histocompatibility leukocyte antigen expression by cytomegalovirus-activated T cells. Am J Pathol 1996; 148:105.
  75. Brenner BM, Milford EL. Nephron underdosing: a programmed cause of chronic renal allograft failure. Am J Kidney Dis 1993; 21:66.
  76. de Fijter JW, Mallat MJ, Doxiadis II, et al. Increased immunogenicity and cause of graft loss of old donor kidneys. J Am Soc Nephrol 2001; 12:1538.
  77. Brenner BM, Cohen RA, Milford EL. In renal transplantation, one size may not fit all. J Am Soc Nephrol 1992; 3:162.
  78. Kim YS, Moon JI, Kim DK, et al. Ratio of donor kidney weight to recipient bodyweight as an index of graft function. Lancet 2001; 357:1180.
  79. Moreso F, Serón D, Anunciada AI, et al. Recipient body surface area as a predictor of posttransplant renal allograft evolution. Transplantation 1998; 65:671.
  80. Kasiske BL, Snyder JJ, Gilbertson D. Inadequate donor size in cadaver kidney transplantation. J Am Soc Nephrol 2002; 13:2152.
  81. Giral M, Nguyen JM, Karam G, et al. Impact of graft mass on the clinical outcome of kidney transplants. J Am Soc Nephrol 2005; 16:261.
  82. Oh CK, Jeon KO, Kim HJ, et al. Metabolic demand and renal mass supply affecting the early graft function after living donor kidney transplantation. Kidney Int 2005; 67:744.
  83. Nishimura Y, Tomikawa S, Beck Y, et al. Kidney graft weight as an important risk factor for long-term graft survival. Transplant Proc 1998; 30:107.
  84. Giral M, Foucher Y, Karam G, et al. Kidney and recipient weight incompatibility reduces long-term graft survival. J Am Soc Nephrol 2010; 21:1022.
  85. Smith AY, Van Buren CT, Lewis RM, et al. Factors determining renal transplant outcome at the University of Texas at Houston. Clin Transpl 1987; :155.
  86. Burke G, Esquenazi V, Gharagozloo H, et al. Long-term results of kidney transplantation at the University of Miami. Clin Transpl 1989; :215.
  87. Matas AJ, Humar A, Gillingham KJ, et al. Five preventable causes of kidney graft loss in the 1990s: a single-center analysis. Kidney Int 2002; 62:704.
  88. Butler JA, Roderick P, Mullee M, et al. Frequency and impact of nonadherence to immunosuppressants after renal transplantation: a systematic review. Transplantation 2004; 77:769.
  89. Sanders CE Jr, Curtis JJ. Role of hypertension in chronic renal allograft dysfunction. Kidney Int Suppl 1995; 52:S43.
  90. Cheigh JS, Haschemeyer RH, Wang JC, et al. Hypertension in kidney transplant recipients. Effect on long-term renal allograft survival. Am J Hypertens 1989; 2:341.
  91. Opelz G, Wujciak T, Ritz E. Association of chronic kidney graft failure with recipient blood pressure. Collaborative Transplant Study. Kidney Int 1998; 53:217.
  92. Kasiske BL, Anjum S, Shah R, et al. Hypertension after kidney transplantation. Am J Kidney Dis 2004; 43:1071.
  93. Mange KC, Cizman B, Joffe M, Feldman HI. Arterial hypertension and renal allograft survival. JAMA 2000; 283:633.
  94. Hariharan S, Adams MB, Brennan DC, et al. Recurrent and de novo glomerular disease after renal transplantation: a report from Renal Allograft Disease Registry (RADR). Transplantation 1999; 68:635.
  95. Briganti EM, Russ GR, McNeil JJ, et al. Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med 2002; 347:103.
  96. Andresdottir MB, Hoitsma AJ, Assmann KJ, et al. The impact of recurrent glomerulonephritis on graft survival in recipients of human histocompatibility leucocyte antigen-identical living related donor grafts. Transplantation 1999; 68:623.
  97. 2009 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1999-2008. U.S. Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD. http://www.ustransplant.org/annual_reports/current/.
  98. Tojimbara T, Fuchinoue S, Iwadoh K, et al. Improved outcomes of renal transplantation from cardiac death donors: a 30-year single center experience. Am J Transplant 2007; 7:609.
  99. Bernat JL, D'Alessandro AM, Port FK, et al. Report of a National Conference on Donation after cardiac death. Am J Transplant 2006; 6:281.
  100. Punch JD, Hayes DH, LaPorte FB, et al. Organ donation and utilization in the United States, 1996-2005. Am J Transplant 2007; 7:1327.
  101. Snoeijs MG, Schaefer S, Christiaans MH, et al. Kidney transplantation using elderly non-heart-beating donors: a single-center experience. Am J Transplant 2006; 6:1066.
  102. Doshi MD, Hunsicker LG. Short- and long-term outcomes with the use of kidneys and livers donated after cardiac death. Am J Transplant 2007; 7:122.
  103. Weber M, Dindo D, Demartines N, et al. Kidney transplantation from donors without a heartbeat. N Engl J Med 2002; 347:248.
  104. Droupy S, Blanchet P, Eschwège P, et al. Long-term results of renal transplantation using kidneys harvested from non-heartbeating donors: a 15-year experience. J Urol 2003; 169:28.
  105. Cooper JT, Chin LT, Krieger NR, et al. Donation after cardiac death: the university of wisconsin experience with renal transplantation. Am J Transplant 2004; 4:1490.
  106. Keizer KM, de Fijter JW, Haase-Kromwijk BJ, Weimar W. Non-heart-beating donor kidneys in the Netherlands: allocation and outcome of transplantation. Transplantation 2005; 79:1195.
  107. Moore J, McKnight AJ, Simmonds MJ, et al. Association of caveolin-1 gene polymorphism with kidney transplant fibrosis and allograft failure. JAMA 2010; 303:1282.
  108. Fischereder M, Luckow B, Hocher B, et al. CC chemokine receptor 5 and renal-transplant survival. Lancet 2001; 357:1758.
  109. Brown KM, Kondeatis E, Vaughan RW, et al. Influence of donor C3 allotype on late renal-transplantation outcome. N Engl J Med 2006; 354:2014.
  110. Varagunam M, Yaqoob MM, Döhler B, Opelz G. C3 polymorphisms and allograft outcome in renal transplantation. N Engl J Med 2009; 360:874.
  111. Radermacher J, Mengel M, Ellis S, et al. The renal arterial resistance index and renal allograft survival. N Engl J Med 2003; 349:115.
  112. Elster EA, Hale DA, Mannon RB, et al. Surgical transplant physical examination: correlation of renal resistance index and biopsy-proven chronic allograft nephropathy. J Am Coll Surg 2005; 200:552.
  113. Loock MT, Bamoulid J, Courivaud C, et al. Significant increase in 1-year posttransplant renal arterial index predicts graft loss. Clin J Am Soc Nephrol 2010; 5:1867.
  114. Kolonko A, Chudek J, Zejda JE, Wiecek A. Impact of early kidney resistance index on kidney graft and patient survival during a 5-year follow-up. Nephrol Dial Transplant 2012; 27:1225.
  115. Naesens M, Heylen L, Lerut E, et al. Intrarenal resistive index after renal transplantation. N Engl J Med 2013; 369:1797.
  116. Winkelmayer WC, Kramar R, Curhan GC, et al. Fasting plasma total homocysteine levels and mortality and allograft loss in kidney transplant recipients: a prospective study. J Am Soc Nephrol 2005; 16:255.
  117. Bostom AG, Carpenter MA, Hunsicker L, et al. Baseline characteristics of participants in the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial. Am J Kidney Dis 2009; 53:121.
  118. Halimi JM, Buchler M, Al-Najjar A, et al. Urinary albumin excretion and the risk of graft loss and death in proteinuric and non-proteinuric renal transplant recipients. Am J Transplant 2007; 7:618.
  119. Halimi JM, Laouad I, Buchler M, et al. Early low-grade proteinuria: causes, short-term evolution and long-term consequences in renal transplantation. Am J Transplant 2005; 5:2281.